OPTBF (OptiBiotix Health) Valuation Rank


OPTBF OptiBiotix Health PLC OPTBF
39 GF Score
Price $0.11
GF Value $0.51
! 4 Warning Signs
View Full Analysis

What is OptiBiotix Health Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

OptiBiotix Health Valuation Rank Related Terms

OPTBF
39GF Score
OptiBiotix Health PLC OPTBF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OptiBiotix Health (OPTBF) Overvalued in 2026?

Based on GuruFocus' analysis, OptiBiotix Health stock appears to be undervalued. The current stock price of $0.11 is trading 78.4% below its estimated GF Value™ of $0.51.

Key valuation signals for OPTBF:

  • Valuation Rank:
  • GF Value™: $0.51 vs. price of $0.11 (78.4% below fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the OPTBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OptiBiotix Health Business Description

Other Exchanges OPTI:UK
Address Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
39GF Score

Get the complete analysis for OPTBF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.51
GF Value